
Breakthrough Cell Therapy Demonstrates Promising Outcomes in Treating Advanced Tumors
A groundbreaking development in cancer immunotherapy has emerged from Dresden University Hospital, where researchers have announced promising results from a phase 1 clinical trial utilizing T cell receptor (TCR)-engineered T cells. This innovative approach …